Drugs of abuse effects on immunity and microbial pathogenesis

Journal of Neuroimmune Pharmacology

Volumn 6, Issue 4, 2011, Pages 435-438

  Roy, Sabita ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Drugs of abuse; Human immunodeficiency virus; Immune disfunction; Infectious diseases; Innate and adaptive immunity; Microbial pathogenesis; Opportunistic infections; Pathobiology; Substance abuse

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; METHAMPHETAMINE; MORPHINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ALCOHOL ABUSE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; LUNG INFECTION; MALARIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; TETANUS; WORLD HEALTH ORGANIZATION;

HUMANS; OPPORTUNISTIC INFECTIONS; PERIODICALS AS TOPIC; PREVALENCE; STREET DRUGS;

EID: 81355148605     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-011-9318-z     Document Type: Review

References (28)

1. AC Abt O Meucci 2011 Regulation of neuronal ferritin heavy chain, a new player in opiate-induced chemokine dysfunction J Neuroimmune Pharmacol 6 4
2. C Aceijas GV Stimson M Hickman T Rhodes 2004 Global overview of injecting drug use and HIV infection among injecting drug users AIDS 18 17 2295 2303 15577542 10.1097/00002030-200411190-00010 (Pubitemid 39620222)
3. A Brack HL Rittner C Stein 2011 Immunosuppressive effects of opioids-clinical relevance J Neuroimmune Pharmacol 6 4
4. JM Breslow MA Monroy JM Daly JJ Meissler J Gaughan MW Adler TK Eisenstein 2011 Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection J Neuroimmune Pharmacol 6 4
5. S Buch H Yao M Guo T Mori TP Su J Wang 2011 Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction J Neuroimmune Pharmacol 6 4 10.1007/s11481-010-9229-4
6. Centers for Disease Control and Prevention NCfCDPaHP, Office on Smoking and Health, U.S. Department of Health and Human Services (2007) Comprehensive Tobacco Control Programs. In Best Practices for Comprehensive Tobacco Control Programs-2007
7. JA Cook 2011 Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission Life Sci 88 21-22 931 939 21219914 10.1016/j.lfs.2011.01.003 1:CAS:528:DC%2BC3MXmsVGhurc%3D
8. D Fraga ES Raborn GA Ferreira GA Cabral 2011 Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat J Neuroimmune Pharmacol 6 4
9. S Hu WS Sheng RB Rock 2011 Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis J Neuroimmune Pharmacol 6 4
10. DE Kaminsky TJ Rogers 2011 Nociceptin/orphanin FQ receptor-driven heterologous desensitization of the major HIV-1 co-receptor CXCR4 J Neuroimmune Pharmacol 6 4
11. AG Karaji D Reiss A Matifas BL Kieffer C Gaveriaux-Ruff 2011 Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors J Neuroimmune Pharmacol 6 4
12. KS Kaushik K Kapila AK Praharaj 2011 Shooting up: the interface of microbial infections and drug abuse J Med Microbiol 60 Pt 4 408 422 21389334 10.1099/jmm.0.027540-0
13. JH Khalsa A Elkashef 2010 Interventions for HIV and hepatitis C virus infections in recreational drug users Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 50 11 1505 1511 10.1086/652447
14. NJ Lecapitaine P Zhang P Winsauer E Walker C Vande Stouwe C Porretta PE Molina 2011 Chronic delta-9-tetrahydrocannabinol administration increases lymphocyte CXCR4 expression in rhesus macaques J Neuroimmune Pharmacol 6 4
15. PE Molina A Amedee NJ Lecapitaine J Zabaleta M Mohan P Winsauer C Vande Stouwe 2011 Cannabinoid neuroimmune modulation of SIV disease J Neuroimmune Pharmacol 6 4
16. Murray M, Hogg R, Lima V, May M, Moore D, Abgrall S, Bruyand M, D'Arminio Monforte A, Tural C, Gill M, Harris R, Reiss P, Justice A, Kirk O, Saag M, Smith C, Weber R, Rockstroh J, Khaykin P, Sterne J (2011) The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine, in Press.
17. M Olin K Choi TW Molitor 2011 Morphine alters M. bovis infected microglia's ability to activate gammadelta T lymphocytes J Neuroimmune Pharmacol 6 4
18. UNODC (2004) The economic costs of drug abuse in the United States, 1992-2002. Washington, DC
19. V Purohit R Rapaka D Shurtleff 2011 Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia Mol Neurobiol 44 1 102 110 21717292 10.1007/s12035-011-8195-z 1:CAS:528:DC%2BC3MXos1yhur8%3D
20. S Razani-Boroujerdi RJ Langley SP Singh JC Pena-Philippides J Rir-Sima-Ah S Gundavarapu NC Mishra ML Sopori 2011 The role of IL-1beta in nicotine-induced immunosuppression and neuroimmune communication J Neuroimmune Pharmacol 6 4
21. J Rehm C Mathers S Popova M Thavorncharoensap Y Teerawattananon J Patra 2009 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders Lancet 373 9682 2223 2233 19560604 10.1016/S0140-6736(09)60746-7
22. S Roy J Wang J Kelschenbach L Koodie J Martin 2006 Modulation of immune function by morphine: implications for susceptibility to infection J Neuroimmune Pharmacol 1 1 77 89 18040793 10.1007/s11481-005-9009-8 (Pubitemid 44257502)
23. S Roy J Ninkovic S Banerjee RG Charboneau S Das R Dutta VA Kirchner L Koodie J Ma J Meng RA Barke 2011 Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections J Neuroimmune Pharmacol 6 4
24. A Sharma XT Hu TC Napier L Al-Harthi 2011 Methamphetamine and HIV-1 Tat down Regulate beta-catenin signaling: implications for methampetamine abuse and HIV-1 Co-morbidity J Neuroimmune Pharmacol 6 4
25. A Ritter 2009 Methods for comparing drug policies-the utility of composite drug harm indexes Int J Drug Pol 6 475 10.1016/j.drugpo.2009.02.012
26. J Wang RA Barke J Ma R Charboneau S Roy 2008 Opiate abuse, innate immunity, and bacterial infectious diseases Archivum immunologiae et therapiae experimentalis 56 5 299 309 18836861 10.1007/s00005-008-0035-0 1:CAS:528:DC%2BD1cXhsVaiur3I
27. X Wang WZ Ho 2011 Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission Life Sci 88 21-22 972 979 21056582 10.1016/j.lfs.2010.10.029 1:CAS:528:DC%2BC3MXmsVGhu7o%3D
28. X Wang T Zhang WZ Ho 2011 Opioids and HIV/HCV infection J Neuroimmune Pharmacol 6 4